mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |